Mitsubishi UFJ Trust & Banking
MDGL icon

Mitsubishi UFJ Trust & Banking’s Madrigal Pharmaceuticals MDGL Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$622K Buy
+1,158
New +$593K ﹤0.01% 992

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's MDGL Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 1,158 shares worth $622K. The stake represents ﹤0.01% of the portfolio and ranks #992 among its holdings.

413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 1,158 shares of Madrigal Pharmaceuticals worth $622K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #992 holding.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.